Paxman AB (publ) (STO:PAX)
Sweden · Delayed Price · Currency is SEK 51.60
+0.60 (1.18%)
May 25, 2026, 5:29 PM CET
Paxman AB Company Description
Paxman AB (publ), together with its subsidiaries, provides cryotherapy solutions in the United Kingdom, Europe, North and South America, Oceania, and Asia.
The company offers Paxman scalp cooling system, a mechanized form of scalp cooling for the prevention of chemotherapy-induced alopecia.
It also engages in the development of a medical cryocompression device for the prevention of chemotherapy-induced peripheral neuropathy.
The company was founded in 1996 and is based in Karlshamn, Sweden.
Paxman AB (publ)
| Country | Sweden |
| Founded | 1996 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 144 |
| CEO | Richard Paxman |
Contact Details
Address: Pirgatan 13 Karlshamn, 374 35 Sweden | |
| Website | paxmanscalpcooling.com |
Stock Details
| Ticker Symbol | PAX |
| Exchange | Nasdaq Stockholm |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| ISIN Number | SE0009806284 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Liza Hirst | EA to Chief Executive Officer and Head of Human Resources |
| Richard Paxman O.B.E. | Chief Executive Officer and Director |
| Emelie Gustafsson | Chief Financial Officer |
| Alexandra Sheldrake | Head of Operations |
| Dr. Simon Taylor | Technical Manager |
| Louise Aspey-Smith | Head of Brand and Marketing Manager |
| Claire Paxman | Head of Clinical Practice and Education |
| Patrick Burke | Head of Research and Development |
| Emma Thornhill | Group Finance Director |
| Stuart Rowling | Head of UK Sales and Training |